Shannon Takala‐Harrison

Understanding the Intransigence of Malaria in Malawi

Genetic architecture of artemisinin-resistant Plasmodium falciparum

<i>Ex Vivo</i> Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance

Persistence of Sulfadoxine-Pyrimethamine Resistance Despite Reduction of Drug Pressure in Malawi

Hemoglobin C Trait Provides Protection From Clinical Falciparum Malaria in Malian Children

The effect of local variation in malaria transmission on the prevalence of sulfadoxine–pyrimethamine resistant haplotypes and selective sweep characteristics in Malawi

Independent Emergence of Artemisinin Resistance Mutations Among Plasmodium falciparum in Southeast Asia

Return of Widespread Chloroquine-Sensitive Plasmodium falciparum to Malawi

Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications

A microarray platform and novel SNP calling algorithm to evaluate Plasmodium falciparum field samples of low DNA quantity

Plasmodium falciparum field isolates from areas of repeated emergence of drug resistant malaria show no evidence of hypermutator phenotype

Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia

Extended Safety, Immunogenicity and Efficacy of a Blood-Stage Malaria Vaccine in Malian Children: 24-Month Follow-Up of a Randomized, Double-Blinded Phase 2 Trial

Seroreactivity to Plasmodium falciparum Erythrocyte Membrane Protein 1 Intracellular Domain in Malaria-Exposed Children and Adults

Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing

Genetic loci associated with delayed clearance of <i>Plasmodium falciparum</i> following artemisinin treatment in Southeast Asia

Molecular Basis of Allele-Specific Efficacy of a Blood-Stage Malaria Vaccine: Vaccine Development Implications